Stem cell therapy clinical trial halted by the FDA

Darkfrog submitted, created time 7 months 2 weeks (www.nature.com)

The FDA has put the brakes on a clinical trial, mentioned on DiscoveR8 a few months ago: Geron company in California wants to inject the spines of spinal injury patients with oligodendroglial progenitor cells grown from embryonic stem cells.

At first I thought, "Good, a little caution never hurt anyone," but then I read that this trial has been in the works for four years. You know what? That four-year delay probably has hurt someone.

The FDA has NOT STATED ITS REASONS for the delay

2 comments | Blog It | Email It | Keywords: stem cells stem cell research embryonic stem cells oligodendrocyte progenitor cells paralysis spinal injuries spinal cord spinal cord injuries FDA law politics